This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Zafiropoulos, A. Articles by Tzanakakis, G. N. PubMed PubMed Citation Articles by Zafiropoulos, A. Articles by Tzanakakis, G. N.

---

Cell Cycle, Cell Death, and Senescence

Decorin-Induced Growth Inhibition Is Overcome through Protracted Expression and Activation of Epidermal Growth Factor Receptors in Osteosarcoma Cells

Departments of ¹ Histology, ² Orthopedics, and ³ Toxicology, Medical School, University of Crete, Heraklion, Greece; and ⁴ Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece

Requests for reprints: G.N. Tzanakakis, Department of Histology, Division of Morphology, School of Medicine, University of Crete, 71110 Heraklion, Greece. Phone/Fax: 30-28-1039-4719. E-mail tzanakak{at}med.uoc.gr

Decorin is an established natural oncosuppressive factor whose action is being studied in detail. Recently, decorin gene therapy formulations using adenoviral vectors have been shown in several animal models with very promising results. The present study describes the first exception to the established oncosuppression model using human osteosarcoma cells. MG-63 osteosarcoma cells were found to constitutively produce decorin, and furthermore, to be resistant to decorin-induced growth arrest. On the contrary, decorin seemed to be beneficial to osteosarcoma cells because it was necessary for MG-63 cell migration and acted as a mediator, counteracting the transforming growth factor-β2–induced cytostatic function. Efforts to determine how MG-63 cells could overcome the decorin-induced cytostatic effect established that decorin in MG-63 cells does not induce p21 expression nor does it cause protracted retraction and inactivation of the epidermal growth factor receptor. Conversely, epidermal growth factor receptor seemed to be overexpressed and continuously phosphorylated. In view of the proposed design of decorin-based anticancer therapeutic strategies, our study provides new data on pathways that cancer cells might employ to overcome the established decorin-induced growth suppression. (Mol Cancer Res 2008;6(5):785–94)